Skip to main navigation
Skip to search
Skip to main content
Projects and Grants
Press / Media
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Phase 2 Placebo-controlled Double blind Trial of Dasatin
Greeno, Edward W
Medicine - Hematology, Oncology, Transplant
Phase 2 Placebo-controlled Double blind Trial of Dasatinib added to Gemcitabine for Subjects with Locallyadvanced Pancreatic Cancer
Effective start/end date
OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint